针对独立细胞通路和免疫的相互作用:癌症免疫疗法的挑战
Angela Lauriola1, Pierpaola Davalli2, Gaetano Marverti2
1Department of Biotechnology, University of Verona, 37134 Verona, Italy.
Cancers
|June 10, 2023
概括
癌症免疫疗法利用免疫系统对抗瘤,但并非所有患者都受益. 结合针对不同途径的疗法,有望改善癌症治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 癌症免疫疗法利用免疫系统对抗癌症,彻底改变了治疗方法,并改善了一些患者的治疗结果.
- 尽管取得了进展,但许多患者对当前的免疫疗法策略没有反应.
- 针对独立,协同的细胞通路的组合疗法是未来癌症免疫疗法发展的关键领域.
研究的目的:
- 审查瘤细胞死亡和免疫参与对氧化应激和无素酶通路的影响.
- 确定癌症免疫疗法和免疫调节点的有希望的组合.
- 讨论成像在监测治疗反应和免疫治疗副作用方面的作用.
主要方法:
- 关于癌症免疫疗法,瘤细胞死亡,免疫系统参与,氧化应激和泛素酶通路的文献综述.
- 对癌症免疫治疗的协同组合策略的分析.
- 讨论用于治疗监测的成像技术.
主要成果:
- 瘤细胞死亡和免疫激活影响氧化应激和无素酶通路.
- 特定的免疫疗法组合和免疫调节标显示出潜在的协同效应.
- 图像检测对于评估治疗疗效和管理副作用至关重要.
结论:
- 组合免疫疗法策略具有提高癌症治疗疗效的巨大潜力.
- 需要进一步的研究来探索协同作用的组合和优化免疫调节标.
- 先进的成像技术对于个性化癌症免疫治疗监测和管理至关重要.
相关概念视频
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Cytotoxic T Cells-mediated Immune Response
1.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.0K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K


